Review
Aug 2026
Clinical characteristics, management and outcomes in immune checkpoint inhibitor-induced central nervous system demyelinating disease
Patients with central nervous system demyelinating disease (ICI-CDD) should be suspected in patients receiving ICI therapy who present with unexplained paraparesis, sensory deficits, sphincter dysfunction, visual loss, or visual field defects, thereby improving clinical outcomes.
Zhong-Mian Ma, Wei-Bin Xie, Yan-Lei Hao et al.
· Neurological Sciences · 0 citations